Company - Newcells Biotech : Overview | A2A
Explore
Companies
Newcells Biotech
Newcells Biotech uses 3D in vitro modelling expertise to develop nephrotoxicity and renal transporter assays that most accurately predict in vivo outcomes, as well as producing fully developed hiPSC-derived Retinal Organoids.